These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8022866)

  • 1. Cyclothialidine and its congeners: a new class of DNA gyrase inhibitors.
    Goetschi E; Angehrn P; Gmuender H; Hebeisen P; Link H; Masciadri R; Nielsen J
    Pharmacol Ther; 1993 Nov; 60(2):367-80. PubMed ID: 8022866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.
    Nakada N; Shimada H; Hirata T; Aoki Y; Kamiyama T; Watanabe J; Arisawa M
    Antimicrob Agents Chemother; 1993 Dec; 37(12):2656-61. PubMed ID: 8109932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclothialidine, a novel DNA gyrase inhibitor. II. Isolation, characterization and structure elucidation.
    Kamiyama T; Shimma N; Ohtsuka T; Nakayama N; Itezono Y; Nakada N; Watanabe J; Yokose K
    J Antibiot (Tokyo); 1994 Jan; 47(1):37-45. PubMed ID: 8119860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
    Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
    J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclothialidine, a novel DNA gyrase inhibitor. I. Screening, taxonomy, fermentation and biological activity.
    Watanabe J; Nakada N; Sawairi S; Shimada H; Ohshima S; Kamiyama T; Arisawa M
    J Antibiot (Tokyo); 1994 Jan; 47(1):32-6. PubMed ID: 8119859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new DNA gyrase inhibitor subclass of the cyclothialidine family based on a bicyclic dilactam-lactone scaffold. Synthesis and antibacterial properties.
    Angehrn P; Goetschi E; Gmuender H; Hebeisen P; Hennig M; Kuhn B; Luebbers T; Reindl P; Ricklin F; Schmitt-Hoffmann A
    J Med Chem; 2011 Apr; 54(7):2207-24. PubMed ID: 21388139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
    Nakada N; Gmünder H; Hirata T; Arisawa M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and Evaluation of N-Phenylpyrrolamides as DNA Gyrase B Inhibitors.
    Durcik M; Tammela P; Barančoková M; Tomašič T; Ilaš J; Kikelj D; Zidar N
    ChemMedChem; 2018 Jan; 13(2):186-198. PubMed ID: 29206345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N-phenylpyrrolamide DNA gyrase B inhibitors: Optimization of efficacy and antibacterial activity.
    Durcik M; Lovison D; Skok Ž; Durante Cruz C; Tammela P; Tomašič T; Benedetto Tiz D; Draskovits G; Nyerges Á; Pál C; Ilaš J; Peterlin Mašič L; Kikelj D; Zidar N
    Eur J Med Chem; 2018 Jun; 154():117-132. PubMed ID: 29778894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New N-phenyl-4,5-dibromopyrrolamides and N-Phenylindolamides as ATPase inhibitors of DNA gyrase.
    Zidar N; Tomašič T; Macut H; Sirc A; Brvar M; Montalvão S; Tammela P; Ilaš J; Kikelj D
    Eur J Med Chem; 2016 Jul; 117():197-211. PubMed ID: 27100032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrrolopyrimidine inhibitors of DNA gyrase B (GyrB) and topoisomerase IV (ParE), Part II: development of inhibitors with broad spectrum, Gram-negative antibacterial activity.
    Trzoss M; Bensen DC; Li X; Chen Z; Lam T; Zhang J; Creighton CJ; Cunningham ML; Kwan B; Stidham M; Nelson K; Brown-Driver V; Castellano A; Shaw KJ; Lightstone FC; Wong SE; Nguyen TB; Finn J; Tari LW
    Bioorg Med Chem Lett; 2013 Mar; 23(5):1537-43. PubMed ID: 23294697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Bacterial Topoisomerase Inhibitors with Potent Broad-Spectrum Activity against Drug-Resistant Bacteria.
    Charrier C; Salisbury AM; Savage VJ; Duffy T; Moyo E; Chaffer-Malam N; Ooi N; Newman R; Cheung J; Metzger R; McGarry D; Pichowicz M; Sigerson R; Cooper IR; Nelson G; Butler HS; Craighead M; Ratcliffe AJ; Best SA; Stokes NR
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA gyrase inhibitors: Progress and synthesis of potent compounds as antibacterial agents.
    Khan T; Sankhe K; Suvarna V; Sherje A; Patel K; Dravyakar B
    Biomed Pharmacother; 2018 Jul; 103():923-938. PubMed ID: 29710509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, antimicrobial, cytotoxic and E. coli DNA gyrase inhibitory activities of coumarinyl amino alcohols.
    Priyanka ; Singh V; Ekta ; Katiyar D
    Bioorg Chem; 2017 Apr; 71():120-127. PubMed ID: 28196603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and development of kibdelomycin, a new class of broad-spectrum antibiotics targeting the clinically proven bacterial type II topoisomerase.
    Singh SB
    Bioorg Med Chem; 2016 Dec; 24(24):6291-6297. PubMed ID: 27143131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular docking, discovery, synthesis, and pharmacological properties of new 6-substituted-2-(3-phenoxyphenyl)-4-phenyl quinoline derivatives; an approach to developing potent DNA gyrase inhibitors/antibacterial agents.
    Alagumuthu M; Arumugam S
    Bioorg Med Chem; 2017 Feb; 25(4):1448-1455. PubMed ID: 28094220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mode of action of closthioamide: the first member of the polythioamide class of bacterial DNA gyrase inhibitors.
    Chiriac AI; Kloss F; Krämer J; Vuong C; Hertweck C; Sahl HG
    J Antimicrob Chemother; 2015 Sep; 70(9):2576-88. PubMed ID: 26174721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclothialidine analogs, novel DNA gyrase inhibitors.
    Yamaji K; Masubuchi M; Kawahara F; Nakamura Y; Nishio A; Matsukuma S; Fujimori M; Nakada N; Watanabe J; Kamiyama T
    J Antibiot (Tokyo); 1997 May; 50(5):402-11. PubMed ID: 9207910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining molecular docking and QSAR studies for modelling the antigyrase activity of cyclothialidine derivatives.
    Saíz-Urra L; Cabrera Pérez MÁ; Helguera AM; Froeyen M
    Eur J Med Chem; 2011 Jul; 46(7):2736-47. PubMed ID: 21530019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure activity relationship of C-2 ether substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-5).
    Singh SB; Kaelin DE; Meinke PT; Wu J; Miesel L; Tan CM; Olsen DB; Lagrutta A; Fukuda H; Kishii R; Takei M; Takeuchi T; Takano H; Ohata K; Kurasaki H; Nishimura A; Shibata T; Fukuda Y
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3630-5. PubMed ID: 26152426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.